Hackers affiliated with Iran have launched a host of cyberattacks on American biopharmaceutical company Gilead Sciences, Inc. in recent weeks which were discovered and prevented by an Israeli cyber company.
Gilead is the only company so far to have received U.S. approval for experimental use of a drug produced by it in coronavirus patients.